|
Differential requirements for calcium and Src family kinases in platelet GPIIb/IIIa activation and thromboxane generation downstream of different G-protein pathways
Blood. 2005 Abr; 105(7):2749-56. Epub 2004 Nov 16
Dorsam RT, Kim S, Murugappan S, Rachoor S, Shankar H, Jin J, Kunapuli SP |
|
P2Y12 gene H2 haplotype is not associated with increased adenosine diphosphate-induced platelet aggregation after initiation of clopidogrel therapy with a high loading dose
Blood Coagul Fibrinolysis. 2005 Abr; 16(3):199-204.
von Beckerath N, von Beckerath O, Koch W, Eichinger M, Schomig A, Kastrati A |
|
Immunolocalization of platelet glycoprotein IIb/IIIa and P-selectin, and neutrophil-platelet interaction in human coronary unstable plaques
Int J Mol Med. 2005 Abr; 15(4):573-7.
Ikuta T, Naruko T, Ikura Y, Ohsawa M, Fukushima H, Shirai N, Itoh A, Haze K, Ehara S, Sasaki Y, Shibata T, Suehiro S, Ueda M |
|
Primary and secondary thrombocytosis in childhood
Br J Haematol. 2005 Abr; 129(2):165-77.
Dame C, Sutor AH |
|
Clopidogrel and ticlopidine: P2Y12 adenosine diphosphate-receptor antagonists for the prevention of atherothrombosis
Semin Thromb Hemost. 2005 Abr; 31(2):174-83.
Savi P, Herbert JM |
|
Comparison of the safety and efficacy of emboli prevention devices versus platelet glycoprotein IIb/IIIa inhibition during carotid stenting
Am J Cardiol. 2005 Mar; 95(6):791-5.
Chan AW, Yadav JS, Bhatt DL, Bajzer CT, Gum PA, Roffi M, Cho L, Agah R, Topol EJ |
|
Aspirin resistance and a single gene
Am J Cardiol. 2005 Mar; 95(6):805-8.
Jefferson BK, Foster JH, McCarthy JJ, Ginsburg G, Parker A, Kottke-Marchant K, Topol EJ |
|
Differential regulation and relocalization of the platelet P2Y receptors after activation: a way to avoid loss of hemostatic properties?
Mol Pharmacol. 2005 Mar; 67(3):721-33. Epub 2004 Dic 15
Baurand A, Eckly A, Hechler B, Kauffenstein G, Galzi JL, Cazenave JP, Leon C, Gachet C |
|
P2Y receptor antagonists in thrombosis
Curr Opin Investig Drugs. 2005 Mar; 6(3):275-82.
Boeynaems JM, van Giezen H, Savi P, Herbert JM |
|
Flavanols and platelet reactivity
Clin Dev Immunol. 2005 Mar; 12(1):1-9.
Pearson DA, Holt RR, Rein D, Paglieroni T, Schmitz HH, Keen CL |
|
Arg333 and Arg334 in the COOH terminus of the human P2Y1 receptor are crucial for Gq coupling
Am J Physiol Cell Physiol. 2005 Mar; 288(3):C559-67. Epub 2004 Oct 27
Ding Z, Tuluc F, Bandivadekar KR, Zhang L, Jin J, Kunapuli SP |
|
The peptide LSARLAF mediates platelet activation through PLCgamma2 independently of GPIIbIIIa.
Biochem J.. 2005 Feb; 378(Pt 1):193-9.
Pearce AC, Wonerow P, Marshall SJ, Frampton J, Gartner TK, Watson SP. |
|
A role for the thiol isomerase protein ERP5 in platelet function
Blood. 2005 Feb; 105(4):1500-7. Epub 2004 Oct 5
Jordan PA, Stevens JM, Hubbard GP, Barrett NE, Sage T, Authi KS, Gibbins JM |
|
A cost-effectiveness analysis of combination antiplatelet therapy for high-risk acute coronary syndromes: clopidogrel plus aspirin versus aspirin alone
Ann Intern Med. 2005 Feb; 142(4):251-9.
Schleinitz MD, Heidenreich PA |
|
ADP acting on P2Y13 receptors is a negative feedback pathway for ATP release from human red blood cells
Circ Res. 2005 Feb; 96(2):189-96. Epub 2004 Dic 16
Wang L, Olivecrona G, Gotberg M, Olsson ML, Winzell MS, Erlinge D |
|
Immune thrombocytopenia caused by glycoprotein IIb/IIIa inhibitors
Chest. 2005 Feb; 127(2 Suppl):53S-59S.
Aster RH |
|
Thrombocytopenia in cardiovascular patients: diagnosis and management
Chest. 2005 Feb; 127(2 Suppl):46S-52S.
Matthai WH Jr |
|
Role of Gas6 receptors in platelet signaling during thrombus stabilization and implications for antithrombotic therapy
J Clin Invest. 2005 Feb; 115(2):237-46.
Angelillo-Scherrer A, Burnier L, Flores N, Savi P, DeMol M, Schaeffer P, Herbert JM, Lemke G, Goff SP, Matsushima GK, Earp HS, Vesin C, Hoylaerts MF, Plaisance S, Collen D, Conway EM, Wehrle-Haller B, Carmeliet P |
|
P2Y12 receptors play a significant role in the development of platelet microaggregation in patients with diabetes
J Clin Endocrinol Metab. 2005 Feb; 90(2):920-7. Epub 2004 Oct 13
Matsuno H, Tokuda H, Ishisaki A, Zhou Y, Kitajima Y, Kozawa O |
|
Platelet glycoprotein IIb/IIIa polymorphism and coronary artery disease: implications for clinical practice
Am J Pharmacogenomics. 2005 Ene; 5(2):93-9.
Di Castelnuovo A, de Gaetano G, Benedetta Donati M, Iacoviello L |
